“Flow Cytometry based ’Acute Myeloid Leukemia Maturity Score’ is a Novel Marker for Predicting Relapse in Acute Myeloid Leukemia: A Prospective Observational Study: AML Maturity Score Predicts Relapse in AML”, ijmsdr, vol. 6, no. 2, Feb. 2022, doi: 10.32553/ijmsdr.v6i2.910.